Founders Capital Management T2 Biosystems, Inc. Transaction History

Founders Capital Management

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	BUY	$0.46 - $0.94 $4,600 - $9,400	10,000 Added 33.33%	40,000 $21,000
Q2 2021 Jul 15, 2021	BUY	$1.04 - $1.69 $8,320 - $13,520	8,000 Added 36.36%	30,000 $36,000
Q1 2021 Jun 07, 2021	SELL	$1.32 - $3.79 $5,280 - $15,160	-4,000 Reduced 15.38%	22,000 $6,000
Q4 2020 Jan 12, 2021	SELL	$1.06 - $1.51 $10,600 - $15,100	-10,000 Reduced 27.78%	26,000 $32,000
Q1 2020 Apr 22, 2020	BUY	$0.28 - $1.23 $5,880 - $25,830	21,000 Added 140.0%	36,000 $23,000
Q4 2019 Jan 24, 2020	SELL	$0.96 - $2.94 $1,920 - $5,880	-2,000 Reduced 11.76%	15,000 $18,000
Q3 2019 Oct 10, 2019	BUY	$0.58 - $3.01 $6,380 - $33,110	11,000 Added 183.33%	17,000 $43,000
Q1 2019 Apr 17, 2019	BUY	$2.56 - $4.48 $2,560 - $4,480	1,000 Added 20.0%	6,000 $16,000
Q4 2018 Jan 14, 2019	BUY	$2.98 - $6.86 $5,960 - $13,720	2,000 Added 66.67%	5,000 $15,000
Q3 2018 Oct 05, 2018	BUY	$5.36 - $7.83 $2,680 - $3,915	500 Added 20.0%	3,000 $22,000
Q2 2018 Jul 09, 2018	BUY	$5.97 - $9.58 $2,985 - $4,790	500 Added 25.0%	2,500 $19,000
Q1 2018 Apr 09, 2018	BUY	$4.21 - $7.0 $8,420 - $14,000	2,000 New	2,000 $13,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.38M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Founders Capital Management, based on Form 13F filings with the SEC.

Stay updated on Founders Capital Management with notifications on news.